AZN-OLD
AstraZeneca PLC
AstraZeneca PLC historical holders
total: 6
Dodge & Cox Stock Fund AstraZeneca PLC transactions over time
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 5
- Held since:
- 2019 Q3
- Held for:
- 6 quarters
- Latest activity:
- 2021 Q1
Dodge & Cox Stock Fund has been an institutional investor in AstraZeneca PLC (AZN-OLD) since 2019 Q3. According to 2026 Q1 report, Dodge & Cox Stock Fund doesn't hold any shares. The fund/company first acquired AZN-OLD in 2019 Q3, initially purchasing about 32.63M shares. Since the initial investment, Dodge & Cox Stock Fund has made 6 more transactions in this position.
When did Dodge & Cox Stock Fund exit their AZN-OLD position?
Dodge & Cox Stock Fund no longer holds AstraZeneca PLC (AZN-OLD). They sold off their entire position in 2021 Q1, closing out an investment that began in 2019 Q3.
When did Dodge & Cox Stock Fund first invest in AZN-OLD?
Dodge & Cox Stock Fund first invested in AstraZeneca PLC (AZN-OLD) in 2019 Q3 at the reported quarter-end price of $44.57 per share, acquiring 32,630,573 shares in their initial purchase.
What is Dodge & Cox Stock Fund's average cost basis for AZN-OLD?
Based on historical transaction data, Dodge & Cox Stock Fund's estimated cost basis for AstraZeneca PLC (AZN-OLD) is approximately $44.57 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $44.57
- Weighted AVG sell price:
- $49.86
AZN-OLD transactions history by Dodge & Cox Stock Fund
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q1
|
0.00%
|
0
|
$49.99
|
|
-100% (-2,049,473)
|
-0.14%
|
|
2020 Q4
|
0.14%
|
$49.99
|
-77.45% (-7,040,700)
|
|||
|
2020 Q3
|
0.82%
|
$54.80
|
-21.20% (-2,445,162)
|
|||
|
2020 Q2
|
1.02%
|
$52.89
|
-37.76% (-6,999,138)
|
|||
|
2020 Q1
|
1.61%
|
$44.66
|
-26.31% (-6,617,900)
|
|||
|
2019 Q4
|
1.68%
|
$49.86
|
-22.92% (-7,478,200)
|
|||
|
2019 Q3
|
2.10%
|
$44.57
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.